← Leaderboards
Chao-Lan Yu
Dana-Farber Cancer Institute
$1,229,270
Attributed
$1,229,270
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $244.6K · FY2006–10$250K$187.5K$125K$62.5K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,229,270 · 2
By mechanism
R01$1,186,642 · 1
F32$42,628 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- Alan N. Engelman$40,161,770
- Scott A Armstrong$21,470,003
- Andrew L Kung$5,571,759
- Han-Fei Ding$7,664,102
- Stephen L Lessnick$7,170,581
Others in their field
Top investigators on “Cell Transformation”
- Hugh Rosen · Scripps Research Institute$67,361,551
- Mary L. Disis · University Of Washington$62,859,950
- Georgia D Tomaras · Fred Hutchinson Cancer Center$58,263,037
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$58,263,037
- Dan H. Barouch · Fred Hutchinson Cancer Center$58,263,037
- Lawrence Corey · Fred Hutchinson Cancer Center$58,263,037
Research focus
Cell TransformationFamilyCancer CellAbl OncogeneBiological ModelsAffectAffinityCancer TherapyBackCell GrowthCellsExhibitsChromatinCis Acting ElementCish GeneComplexCytokineCytokine Inducible Sh2-Containing ProteinCytokine SignalingDefectDna BindingDna MethylationEctopic ExpressionFamily Member
Grant awards (7)
SOCS: Its Regulation and Role in Oncogenesis$235,778
R01 · FY2010 · CA · contact PI
SOCS: Its Regulation and Role in Oncogenesis$235,778
R01 · FY2009 · CA · contact PI
SOCS: Its Regulation and Role in Oncogenesis$234,758
R01 · FY2008 · CA · contact PI
SOCS: Its Regulation and Role in Oncogenesis$235,778
R01 · FY2007 · CA · contact PI
SOCS: Its Regulation and Role in Oncogenesis$155,040
R01 · FY2006 · CA · contact PI
SOCS: Its Regulation and Role in Oncogenesis$89,510
R01 · FY2006 · CA · contact PI
ROLES OF STAT-3 AND STAT-5 IN LCK MEDIATED ONCOGENESIS$42,628
F32 · FY2000 · CA